Experimental vaccine aims to train immune system to fight HPV cancers
NCT ID NCT06319963
Summary
This clinical trial is testing a new vaccine called Lenti-HPV-07 for people with HPV-related throat or cervical cancer. The study aims to see if the vaccine is safe and can trigger the immune system to fight cancer cells. Researchers will enroll 72 participants and follow them for up to one year to monitor their response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Florida Cancer Specialists (from Sarah Canon research Institute)
RECRUITINGOrlando, Florida, 32827, United States
Contact
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
-
Oklahoma Cancer Specialists and Research Institute, LLC
RECRUITINGTulsa, Oklahoma, 74146, United States
Contact
-
Tampa General Hospital
RECRUITINGTampa, Florida, 33606, United States
Contact
Conditions
Explore the condition pages connected to this study.